CAS: 1262618-39-2 - GS967
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 1,2,4-Triazolo[4,3-a]pyridine, 6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)- REF: AN-AG000SFDCAS: 1262618-39-2 | 98+% | 53.00 €~212.00 € | Thu 02 May 24 |
 | GS967 REF: TM-T2049CAS: 1262618-39-2 | 100% | 35.00 €~1,093.00 € | Wed 08 May 24 |
 | GS 967 REF: 3D-FT65033CAS: 1262618-39-2 | Min. 95% | 143.00 €~424.00 € | Tue 14 May 24 |
![1,2,4-Triazolo[4,3-a]pyridine, 6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)-](https://static.cymitquimica.com/products/AN/thumb/AG000SFD.jpg)
1,2,4-Triazolo[4,3-a]pyridine, 6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)-
CAS:1262618-39-2
Formula:
C14H7F6N3O
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
347.2153
Ref: AN-AG000SFD
| 5mg | 53.00 € | |
| 10mg | 70.00 € | |
| 25mg | 111.00 € | |
| 50mg | 185.00 € | |
| 100mg | 212.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
GS967
CAS:1262618-39-2
GS967 is a potent, and selective inhibitor of cardiac late sodium current (late INa ).
Formula:
C14H7F6N3O
Purity:
100%
Color and Shape:
Solid
Molecular weight:
347.22
Ref: TM-T2049
| 2mg | 35.00 € | |
| 5mg | 52.00 € | |
| 10mg | 78.00 € | |
| 25mg | 157.00 € | |
| 50mg | 277.00 € | |
| 100mg | 485.00 € | |
| 200mg | 702.00 € | |
| 500mg | 1,093.00 € | |
| 1ml*10 (DMSO) | 57.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
GS 967
CAS:1262618-39-2
Inhibits cardiac late sodium channel current; antiarrhythmic
Formula:
C14H7F6N3O
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
347.22 g/mol
Ref: 3D-FT65033
| 10mg | 143.00 € | |
| 50mg | 424.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
